Transient receptor potential canonical 3 inhibitors and methods of use thereof (Licensing agreement under negotiation)
- PCT/US2021/054579 (Application filed on October 12, 2021)
Methods and compositions for the treatment of gliomas (Licensed to Nuvision Benefits)
- US10758516 (Issued on September 1, 2020)
Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto (Licensed to Pyrefin Inc.)
- US20220000883 (Application filed on July 15, 2021)
- US11077120 (Issued on August 3, 2021)
- US10568889 (Issued on February 25, 2020)
- US10052332 (Issued on August 21, 2018)
- US10040783 (Issued on August 7, 2018)
- US9518044 (Issued on December 13, 2016)